Arrowhead Pharmaceuticals Inc (ARWR) support and resistance · rev $829.4M
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
This page maps Arrowhead Pharmaceuticals Inc (ARWR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
ARWR currently screens at market cap $10.59B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ARWR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ARWR quote page for the session range and the stock page for the full model.
Not investment advice.